循環性アデノシンモノフォスファートのイノトロピーとルシトロピー作用の相互作用が,心筋細胞に及ぼす影響
1Department of Medicine, University of Connecticut, Farmington 06032.
Circulation
|August 1, 1990
まとめ
ベータアドレナージックアゴニストは,循環性アデノシンモノフォスファート (cAMP) を増加させることで,心臓の収縮とリラックスを促進します. この二重作用は,心拍数が増加したときに心室の充填を改善します.
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- 細胞生理学 細胞生理学
背景:
- ベータアドレナゲンアゴニストは,心筋細胞の循環性アデノシンモノフォスファート (cAMP) レベルを上昇させます.
- cAMPは心筋細胞機能に影響を与え,収縮とリラックスの両方に影響を及ぼします.
- これらの複雑な作用を理解することは,心臓の健康にとって極めて重要です.
研究 の 目的:
- 循環性アデノシンモノフォスファート (cAMP) の心筋細胞における二重イノトロピクおよびルシトロピク効果を解明する.
- ベータアドレナージュアゴニストが心臓の収縮性とリラックスをどのように調節するかを説明する.
- cAMP媒介効果と心室機能の相互作用を明確にするために.
主な方法:
- この研究は,β-アドレナージ信号伝達の分子メカニズムに焦点を当てています.
- 細胞内伝達物質としての循環性アデノシンモノフォスファート (cAMP) の役割を調べています.
- 分析には,カルシウム処理と収縮性タンパク質の感受性を理解することが含まれます.
主要な成果:
- 循環性アデノシンモノフォスファート (cAMP) は,シストーラ中に活性化剤Ca2+の放出を増やすことで収縮性を高めます.
- cAMPは,サルコプラズマ網膜によるCa2+除去を加速し,リラックスを促進します.
- cAMPは,サルコプラズマ網膜のCa2+ポンプの感受性を高め,収縮タンパク質をCa2+に対して無感化します.
結論:
- 周期性アデノシンモノフォスファート (cAMP) のイノトロピクとルジトロピク効果は同時に発生する.
- ベータアドレナゲンアゴニストは,心筋収縮性を高め,リラックスを加速する.
- この効果の組み合わせは,アゴニスト誘発性心拍動症の間,心室の充填を最適化します.
さらに関連する動画
関連する概念動画
01:21G-Protein Gated Ion Channels
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Sensory organs,...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:27Specialized Characteristics of Cardiac Muscles
The primary role of cardiac muscles is to propel blood throughout the cardiovascular system. The cardiac muscle cells, or cardiomyocytes, exhibit specialized characteristics that allow them to perform this function.
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...